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Implementation of an Educational Program and 
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of Antimicrobial Drug Use 
in a Department of Internal Medicine 
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J. W. M. van der Meer 1 
In a study designed to evaluate the effects of an educational program and an antibiot- 
ic order form on the quality of antimicrobial drug use, a prospective analysis was con- 
ducted in the department of internal medicine of a 948-bed university hospital. Follow- 
ing a quality-of-use review of all consecutive courses of antimicrobial drugs prescribed 
during four weeks, an educational program was conducted and an antibiotic order form 
introduced. After four years, an identical review was performed. In the first review, 109 
(31%) of 347 patients were prescribed antimicrobial drugs. Only 40% of the prescrip- 
tions were considered definitely appropriate, and 13% were considered unjustified. There 
was a certain degree of underutilization, and only 67% of clinical isolates were suscep- 
tible to empirical therapy. In the review performed after intervention, 164 (21%) of 796 
patients were given antimicrobial drugs. Defined daily doses per 100 bed days increased 
from 59.8 to 72.6. Fifty-three percent of the prescriptions were judged optimal, and only 
9% were judged unjustified. Ninety percent of the clinical isolates were susceptible to 
empirical therapy. After one year, compliance with the antibiotic order forms on a vol- 
untary basis reached 77%, documenting 86% of antimicrobial drug costs. As a result, 
the antibiotic order form will be useful for surveillance, if logistic support is provided by 
the pharmacy. The combination of several measures leads to improved quality of use. 
As correctly predicted by the first evaluation, improvement in quality resulted in increased 
drug consumption by fewer patients and a higher cost per bed day. 
The increasing cost of antimicrobial drug con- 
sumption, the reports of inappropriate use of an- 
timicrobial drugs (1, 2), and the worldwide in- 
crease in resistance (3) are the main factors on 
which the antibiotic policy measures of the 1990s 
are based. Recently, national antimicrobial drug 
consumption data from European hospitals were 
published by Janknegt et al. (4). Dutch university 
hospitals had a rather low consumption of antimi- 
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crobial drugs (44.3-46.6 defined daily doses per 
100 bed days) compared with German and Belgian 
hospitals, which seems to be reflected by lower re- 
sistance rates in the Netherlands. However, little 
is known about the quality of antimicrobial drug 
use. Criteria for evaluation of the quality of anti- 
microbial drug use are well established (5, 6). 
Many strategies to improve prescribing have 
been described. Education as the sole intervention 
strategy to improve quality has not always been 
successful (7). Antibiotic order forms filled in by 
prescribers have been used to monitor use and to 
influence prescribing habits in the USA (8, 9), but 
experience in Europe is very limited or unpub- 
lished. 
We studied the use of antimicrobial drugs in the 
department of internal medicine of a large univer- 
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sity hosp i ta l .  The  a ims  of  the  s tudy  were  to de f ine  
the  pat terns  of  ant imic rob ia l  d rug  use  in te rms of  
qua l i ty  and  costs;  to  eva luate  the  e f fect  of  an  ed-  
ucat iona l  p rogram;  and  to measure  the  va lue  of  an  
ant ib io t i c  o rder  fo rm.  
Patients and Methods 
Setting. The University Hospital Nijmegen is a 948-bed teach- 
ing hospital. The study took place in selected units of the De- 
partment of Internal Medicine, involving 114 of the 183 beds. 
Some of these units were highly specialized, such as the unit 
of nephrology, where organ transplants are performed. A
large unit of general internal medicine had an older patient 
population. Over the study years, the number of beds re- 
mained unchanged. The number of kidney transplantations 
increased from 90 in the first study year to 111 in the last. At 
the time of the first review, the hospital formulary listed 20 
parenteral nd 26 oral antibacterial drugs. In that year, anti- 
microbial drugs accounted for 22% of the total drug budget 
of 14 million guilders (Dr; approximately US $7 million). 
Hospital formulary drugs were kept in ward-based stocks. 
Pharmacy technicians supplied the drugs to the wards on a 
twice-weekly basis. Nonformulary drugs had to be ordered 
from the pharmacy on special order forms for individual pa- 
tients. Computerized consumption figures were available for 
different wards, but not for individual patients. 
Antimicrobial Utilization Review. The first prospective re- 
view, performed over a four-week period, started in October 
1989. After a period of intervention, a second review was con- 
ducted over a six-week period in 1993. The units I (general in- 
ternal medicine) and N (nephrology) were selected to meas- 
ure the effect of an educational program and an antibiotic or- 
der form, while the unit of pulmonary diseases (P), where no 
order form had been used, was studied as a control. 
Prospective quality-of-use studies were performed by an in- 
fectious diseases physician and junior clinical pharmacists, 
who visited the wards daily and collected ata from medica- 
tion charts on all patients receiving antimicrobial drugs. This 
method has also been applied to surgical departments (10). 
Clinical information was retrieved from patients' records. Ab- 
stracts were made of each consecutive antimicrobial drug 
course. A course was defined as an episode of clinical or sus- 
pected infection or increased risk of infection in which pre- 
scription(s), either consecutively or in combination, were 
written to treat or prevent this particular infection. Infections 
were defined according to the criteria of the Centers for Dis- 
ease Control (11). Nosocomial infection was defined as active 
infection that was not present or incubating at the time of ad- 
mission. Antimicrobial drug use was analyzed quantitatively 
in defined daily doses (DDDs). The DDD represents he av- 
erage therapeutical dose for an adult for the standard indica- 
tion (12). Costs were calculated in guilders using a method of 
global drug-cost calculation, which includes costs of adminis- 
tration and monitoring (13). Results of microbiological tests 
were obtained irectly from the laboratory. 
A quality evaluation of individual prescriptions was per- 
formed by two independent experts in infectious diseases, 
termed reviewer t and 2. They placed prescriptions into cate- 
gories using well-defined criteria. The most authoritative clas- 
sification is that developed by Kunin et al. (5) in 1973. We 
adapted their criteria in order to be able to evaluate ach pa- 
rameter of importance associated with antimicrobial drug 
use. Several subcategofies have been added to the original 
criteria (6). Briefly, prescriptions canbe judged definitely ap- 
propriate (category I) or unjustified (category V), or the 
records can be insufficient for categorization (category VI). 
Other prescriptions are placed in categories II, III, and IV, in- 
dicating inappropriate use. Inappropriate prescriptions can 
be allocated to several categories at the same time: incorrect 
dose (IIa), incorrect interval (IIb), incorrect route (IIc), dura- 
tion too long (IIIa), or duration too short (IIIb). If relevant, 
the reviewers cited an alternative agent deemed better due to 
higher efficacy (IVa), lower toxicity (category IVb), lower 
cost (IVc), or narrower spectrum (IVd). Overall costs of actu- 
al and alternative policies were compared to project savings 
that would result from changes in policy. Because only one 
expert, reviewer 1, was involved in the education and policy 
changes of the intervention, the detailed evaluation results of 
only reviewer 1 are presented. 
Apart from the above-named criteria used by reviewers for 
evaluation, two additional parameters known to be associat- 
ed with good antimicrobial use, i. e., mention of the suspected 
microorganism in the medical record and correct monitoring 
of potentially toxic antimicrobial drugs, were evaluated separ- 
ately. We also determined whether the microorganism isolat- 
ed was susceptible to the drug prescribed initially as empiri- 
cal treatment and if streamlining (14) was performed after 
microbiology results became available. 
Intervention strategies. The principal goal of the interventions 
was to improve the quality of use. An educational program 
was conducted, which consisted of weekly teaching sessions of 
1 h at which one or two cases were presented by an infectious 
diseases specialist. The sessions were attended by 10-25 
medical students, residents, and junior and senior staff mem- 
bers of the department of internal medicine. The case presen- 
tations were interactive and focused on diagnosis and antimi- 
crobial therapy. Resistance patterns, virulence, and principles 
of pharmacokinetics (dosing, frequency) were discussed. Fur- 
thermore, during that period, two infectious diseases pecial- 
ists were available at the weekly grand rounds for clinical con- 
sultation. The order form was introduced uring these teach- 
ing sessions. Newsletters reported to prescribers their actual 
rate of compliance with the order forms, and prescribers could 
compare their compliance data with those of colleagues from 
other wards (data were presented anonymously). 
An update of the antimicrobial drug formulary containing 
guidelines for prophylaxis and therapy was issued. In addition 
to this educational program, an antibiotic order form was in- 
troduced in units I and N in 1992. The form was introduced on 
a voluntary basis, and details are described elsewhere (15). In 
brief, physicians were asked to categorize prescriptions as 
prophylaxis, empiric therapy, or directed therapy. They had to 
state the (presumed) site of infection, (presumed) causative 
microorganism, planned uration of the course, and parame- 
ters such as weight, serum creatinine, and presence of allergy. 
A limited number of formulary antimicrobial drugs and dos- 
age regimens were printed on the form and could be ticked 
off. The order forms were gathered for surveillance purposes 
only; the information on the forms was not used for interven- 
tion. 
Statistical Analyses. Generally, chi-square tests were applied 
to establish systematic differences. Agreement between the 
reviewers was assessed by • coefficients. 
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Table 1: Demographic data and quantitative antimicrobiat drug (AD) use in three units before (first review) and after (second 
review) intervention. 
First review a Second review b 
Unit I Unit N Unit P Total Unit I Unit N Unit P Total 
Total no. of patients 253 52 42 347 576 138 82 796 
No. of patients with AD (%) 57 (23) 30 (58) 22 (52) 109 (31) 85 (15) 45 (33) 34 (41) 164 (21) 
No. of bed days 2200 430 379 3009 2372 626 326 3324 
Total no. of AD courses 73 39 23 135 98 72 38 208 
Prophylactic courses (%) 6 (8) 2 (5) 0 (0) 8 (6) 4 (4) 27 (38) 4 (11) 35 (17) 
Therapeutic courses (%) 67 (92) 37 (95) 23 (100) 127 (94) 94 (96) 45 (62) 34 (89) 173 (83) 
Courses in combination (%) 19 (26) 8 (21) 5 (22) 32 (24) 15 (15) 7 (10) 4 (11) 26 (13) 
Total consumption (no. of DDD) 1231 252 315 1798 1394 672 413 2479 
DDD/100 bed days 56 58.6 83.1 59.8 58.8 107.3 126.7 74.6 
DDD/course 16,9 6.5 13.7 13.3 14.2 9,3 10.9 11.9 
Total cost (Dfl) 18,966 10,874 9773 39,613 35,720 17,338 13,219 66,277 
Total cost/bed day (Dfl) 8.6 25.3 25.8 13.2 15.1 27.7 40.6 19.9 
a One-month review. 
b Six-week review, 
DDD, defined daily doses; Dfi, Dutch guilders; I, general internal medicine; N, nephrology; P, pulmonary medicine. 
Results 
First Review. A detailed analysis of the data from 
the units of general internal medicine (I), nephrol- 
ogy (N), and pulmonary diseases (P) is presented 
in Table 1 to allow comparison with the data of the 
second review. In units I and R 24% of the patients 
were older than 70 years. Thirty-three percent of 
the patients had concomitant corticosteroid use, 
and < 10% were receiving concomitant immuno- 
suppressive drugs. In unit N, none of the patients 
was older than 70 years, and 72% of the patients 
had concomitant corticosteroid therapy with im- 
munosuppressive drugs. 
In the first review, 109 (31%) of 347 patients 
were administered antimicrobial drugs (Table 1). 
There was a large difference in consumption be- 
tween unit I and both units N and R where more 
than half of the patients were treated with antimi- 
crobial drugs. The patients in unit N had the high- 
est consumption in terms of courses/100 bed 
days, but due to renal function impairment, most 
patients had dose reductions that resulted in a rel- 
atively low consumption, expressed in DDD/100 
bed days (Table 1). Unit P had the highest con- 
sumption in DDD/100 bed days, and more than 
three-quarters of the drugs were administered 
orally; in the other units, the majority of the drugs 
were administered parenterally. Combinations of 
two or more drugs were prescribed in 24% of all 
courses. 
The courses were almost exclusively categorized 
as therapy (Table 1). The types of infections 
treated with antimicrobial drugs are presented in
Table 2. Respiratory tract infections were the 
most frequent type of infection treated with anti- 
Table 2: Types of infections treated with therapeutic courses of antimicrobial drugs in three units before and after 
intervention. 
Site of  infection Percent 
First review a Second review b 
Unit I Unit N Unit P Total Unit I Unit N Unit P Total 
(n = 67) (n = 37) (n = 23) (n = 127) (n = 94) (n = 45) (n = 34) (n = 173) 
Respiratory tract 30 32 78 
Urinary tract 9 32 0 
Fever of unknown origin 1 0 4 
Blood 21 8 0 
Abdomen 12 3 0 
Skin/soft t issue 9 5 4 
Miscel laneous/unknown 18 19 13 
39 24 22 82 35 
14 9 29 6 13 
2 4 0 0 2 
13 13 13 3 11 
7 17 0 0 9 
7 14 7 0 9 
17 19 29 9 20 
a One-month review. 
b Six-week review. 
I, general internal medicine; N, nephrology; P, pulmonary medicine. 
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Figure 1: Distribution of antimicrobial drug consumption before and after intervention. Left, distribution in percent total de- 
fined daily doses (DDD); right, distribution in percent total cost. 
microbial drugs (39%). Thirty-four percent of 
these infections were nosocomial. In unit N, uri- 
nary tract infections were most frequent (32%). 
Thirty-three percent of all infections treated 
could be classified as nosocomial. The consump- 
tion of therapeutic antimicrobial drugs, ex- 
pressed as percent total DDD, is presented inFig- 
ure 1. Penicillins accounted for half of the overall 
consumption. Ninety-seven percent of penicillins 
consisted of older penicillins (penicillin G, amox- 
icillin). Twenty-three percent of cephalosporins 
were of the first generation (mainly cefazolin and 
cephalexin), 45% of the second generation 
(mainly cefuroxime), and 32% third generation 
(exclusively ceftazidime). Antifungal and antiviral 
drugs accounted for 16%. 
One course cost an average of Dfl 293. Cost fig- 
ures are presented inTable 1. Overall cost/bed ay 
was Dfl 13.2. However, there were large differenc- 
es in the cost/bed day. Although unit N used 
expensive drugs, its cost/bed day and the cost/ 
course were relatively low due to the previously 
mentioned ose modifications for impaired renal 
function. The distribution of antimicrobial drug 
costs for units I, N, and P combined isgiven in Fig- 
ure 1. More than half of the costs were due to con- 
sumption of cephalosporins and penicillins. 
The most frequently isolated microorganisms 
were Escherichia coli and Klebsiella spp. together 
(20%), Staphylococcus aureus (6%), and Staphy- 
lococcus epidermidis (6%). In Figure 2, the rela- 
tionship between antimicrobial drug prescribing 
and microbiology laboratory utilization is illustrat- 
ed. Microbiology laboratory testing could be stud- 
ied in 123 of 127 therapeutic courses for which the 
site of infection was known. In three-quarters of
these courses, microbiology tests were performed. 
The tests yielded a relevant microorganism in 
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Microbiology laboratory utilization 
before/after intervention 
J 
No (relevant) microorganism isolated 
29 (3 t %) / 53 (41%) 
Therapeutic move (stop) 
7(24%)/ 6(11%) 
Therapeutic courses 
j , ,  123/i54 
Microbiological tests performed 
94 (76%) / 128 (83%) 
Relevant microorganism isolated 
65 (69%) / 75 (59%) 
t 
9 l a t  d ~ " " ' Relevant zso e an empmcm therapy given 
39 (60%) / 39 (52%) 
J 
Microorganism susceptible 
26 (67%) / 35 (90%) 
Therapeutic move (streamlining) 
12 (46%) / 14 (40%) 
No microbiological tests performed 
29 (24%) / 26 (17%) 
x ' •  
Microorganism not susceptible 
13 (32%) / 4 (I0%) 
Change to adequate choice 
6 (46%)/4 (100%) 
Figure 2: Microbiology laboratory utilization and the impact of the laboratory results on prescribing. Only therapeutic anti- 
microbial drug courses were studied (n = 123 before intervention, n = 154 after intervention). 
69%. Only 67% of these microorganisms were sus- 
ceptible to the drugs prescribed as empiric treat- 
ment. In fewer than half of the cases where the mi- 
croorganism was not susceptible, therapy was 
changed to an adequate spectrum. Streamlining of 
empirical therapy was done in 46 % of the cases. In 
only 10% of those who were eligible for stream- 
lining would it have been possible. 
Figure 3 summarizes detailed categories of eval- 
uation of all prescriptions by the two reviewers. 
Two hundred fifty-nine prescriptions could be 
evaluated (categories II, III, and IV could be as- 
signed simultaneously to a prescription). There 
was only moderate agreement (ignoring category 
VI) between the reviewers (• = 0.40). Agreement 
was higher when only categories I (definitely ap- 
propriate) and V (unjustified) were considered 
(~: -- 0.56). Reviewer 2judged more prescriptions 
unjustified than reviewer 1 in all three units. He 
also judged fewer prescriptions definitely appro- 
priate. Table 3 shows the results of the evaluation 
by reviewer 1 for the three units. Fewer than half 
of the prescriptions were judged definitely appro- 
priate (category I), and 13% were judged unjus- 
tified (category V). More than one-third of pre- 
scriptions could be optimized (category II-IV). 
Cost projections were made. Elimination of pre- 
scriptions judged as unjustified by reviewer 1 
would result in a savings of only 8%. The low fre- 
quency of less costly alternatives (category IVc; 
5%) or alternatives with a narrower spectrum 
(category IVd; 3%) did predict minor savings. 
Moreover, because duration of therapy was almost 
never considered too long (category IIIa) and was 
even judged too short (category IIIb) in 2% of pre- 
scriptions, no savings were expected by an im- 
provement inprescribing. Finally, the combination 
of category IIa (incorrect dose, most often too low; 
15%), category IVa (more effective alternative 
wanted; 19%), and the fact that only 67% of the 
microorganisms were susceptible to drugs started 
empirically suggested the need for higher doses of 
drugs with a broader spectrum. It was anticipated 
that implementing the policy of reviewer I would 
result in a cost increase. 
In 16 (23%) of 70 empirical courses, the suspect- 
ed microorganism was mentioned in the medical 
record. Unit P scored best, with six (38%) of 16. 
Formulary drugs were used in 86% of cases (88% 
in unit I, 76% in unit N, 93% in unit P). In all 12 
courses of gentamicin lasting > 72 h, serum con- 
centrations were measured. Courses were given as 
thrice-daily regimens. In four of 12 courses, a 
peak concentration of < 5 rag/1 was measured 
(considered too low), and in four of 12, a trough 
concentration of > 1 mg/1 was measured (consid- 
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Figure 3: Quality evaluation of antimicrobial drug prescriptions by two reviewers before (n = 259) and after (n = 332) inter- 
vention. Left, reviewer 1 ; right, reviewer 2. Categories of evaluation: I, definitely appropriate; Ila, incorrect dose; lib, incorrect 
dosage frequency; IIc, incorrect route, Ilia, too long; Ill b, too short; IVa, alternative agent more effective; IVb, alternative agent 
less toxic; IVc, alternative agent less expensive; IVd, alternative agent less broad spectrum; V, unjustified. 
ered too high). In all courses the dose and/or fre- 
quency was modified. In three courses the second 
peak concentration was still < 5 mg/1. 
Antimicrobial Drug Surveillance between the Two 
Reviews. Between the first review and the second 
review, an update of the antimicrobial drug formu- 
lary was issued, and five antimicrobial drugs were 
added to the formulary: amoxicillin clavulanate, 
ciprofloxacin, trimethoprim, fluconazole, and itra- 
conazole. Five older drugs were removed. 
Surveillance data of the pharmacy showed that ex- 
penses for antimicrobial drugs remained stable in 
1990 but had increased by 35% in 1991 and by 
45% in 1992 in units I and N. In those units, the 
average length of stay had decreased by one day 
between 1989 and 1993. 
Table 3: Evaluation by reviewer 1 of the quality of antimicrobial drug use in three units before and after intervention. 
Evaluation Percent 
First review a Second review b 
Unit I Unit N Unit P Total Unit I Unit N Unit P Total 
(n=143) (n=71) (n=45) (n=259) (n=162) (n=121) (n=49) (n=332) 
Definitely appropriate 
(category I) 41 30 56 40 59 47 47 53 
Unjustified (category V) 11 13 18 13 12 2 18 9 
Inappropriate 
(category II-III-IV) 35 48 24 37 23 37 24 29 
Unevaluable (category Vl) 13 10 2 10 6 14 10 9 
a One-month review9 
b Six-week review9 
I, general internal medicine; N, nephrology; P, pulmonary medicine. 
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The purchase cost of most antimicrobial drugs 
decreased between the times of the two reviews. 
The cost of cephalosporins decreased by 10%, 
and the cost of ciprofloxacin and vancomycin by 
25 %. The antifungal drugs fluconazole and itra- 
conazole, used on a compassionate-use basis in 
the first review, became part of the hospital for- 
mulary, resulting in a cost increase for antifun- 
gal drugs. To analyze the consequences of these 
complex cost changes, a second in-depth review 
was done. 
Second Review. Age distribution and concomitant 
use of corticosteroid and immunosuppressive 
drugs were similar in the second review. 
Table 1 shows the comparison of quantitative 
data. Comparing the units I, N, and R there was a 
reduction in the overall proportion of patients re- 
ceiving antimicrobial drugs, from 31 to 21% 
(Table 1). The difference was significant in unit I 
(p = 0.006) and unit N (p = 0.002), but not in unit 
P (p = 0.25). Overall consumption i creased in 
terms of DDD/100 bed days. Prescription of com- 
binations of two or more antimicrobial drugs de- 
creased from 24 to 13% in the three units. 
Six percent of the courses were intended for pro- 
phylaxis in the first review and 17 % after interven- 
tion (Table 1). This consumption i creased main- 
ly because the Department of Nephrology start- 
ed post-transplantation prophylaxis against 
Pneumocystis carinii with cotrimoxazole. 
Respiratory tract infections were the most fre- 
quent ype treated with antibiotics (Table 2), and 
the sites of infection were very similar. Twenty- 
three percent of respiratory tract infections were 
nosocomial. The consumption of penicillins, 
cephalosporins, and aminoglycosides remained 
stable (Figure 1). The increase in consumption was 
caused by a 90% increase in the use of antiviral 
and antifungal drugs and to slight increases in the 
use of a variety of agents. The consumption of the 
newly added formulary drugs amoxicillin/clavula- 
nate and ciprofloxacin did not increase. 
A comparison of cost parameters before and af- 
ter intervention is shown in Table 1. The total cost/- 
bed day increased from Dfl 13.2 to 19.9. An in- 
crease in cost/bed ay occurred in all three units, 
but was most pronounced inunits I and R A high- 
er cost/DDD, representing the use of more expen- 
sive drugs, and a higher cost/course were noted in 
unit I only.A comparison ofthe distribution of an- 
timicrobial agent costs before and after interven- 
tion is shown in Figure 1. The increase in prophy- 
laxis with oral cotrimoxazole had only a minor in- 
fluence on the costs, as it represented only 4% of 
the total cost. 
During the second review, the data on the antibi- 
otic order forms of units I and N were compared 
with the data collected using the in-depth meth- 
od. Defining compliance as the total number of an- 
tibiotic order forms collected/total number of 
prescriptions, compliance was 77% in unit I and 
50% in unit N. In 98 (58%) of 170 courses, at least 
one order form had been completed. At least one 
form was filled in for 39% of prophylactic cours- 
es and for 61% of therapeutic courses. In unit I, 
86% of total antimicrobial drug costs were docu- 
mented by order forms, but in unit N, it amount- 
ed to only 41%. 
Site of infection and categorization as prophylax- 
is or therapy were well documented in 98% of 
cases in unit I and in 90% in unit N. In empirical- 
ly started therapy, a suspected agent was men- 
tioned in 70% and 62% of cases in these respec- 
tive units. However, some items were regularly 
omitted. History of allergy was most frequently eft 
blank (44%), followed by weight (41%) and crea- 
tinine level (31%). Only 33 % of forms were filled 
in completely. In 98% of the forms, the formulary 
drugs preprinted on the form were chosen. On 
80% of the forms in unit I, preprinted oses and 
dosage intervals were ticked off. In unit N, only 
33% of the preprinted regimens were used. This 
was probably due to dose and/or dosing interval 
adaptations for impaired renal function, although 
this reason was only mentioned on half of those 
forms. 
After the intervention, 96% of the antimicrobial 
drug prescriptions were formulary drugs in unit I 
and N; in unit R it amounted to 89%. The utiliza- 
tion of microbiological tests in therapeutic cours- 
es increased from 76 to 83 % in the second review 
(Figure 2). The yield of relevant microorganisms 
was lower in the second review (59% vs. 69%). 
After intervention, 90% of the isolates were sus- 
ceptible to empirical therapy, compared with 
67% before intervention. All empirical therapy 
was changed to directed therapy with an adequate 
spectrum after culture results were known. 
Three hundred thirty-two prescriptions could be 
evaluated. Figure 3 allows comparison of detailed 
categories ofevaluation of all prescriptions by the 
two reviewers before and after intervention. Af- 
ter intervention, agreement (ignoring category 
VI) between the reviewers was also partial (K = 
0.27). An antimicrobial drug prescription could be 
classified as inappropriate because alternative 
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regimens were available that were considered a 
better choice by one of the reviewers. For exam- 
ple, streamlining cefazolin to flucloxacillin for the 
specific therapy of staphylococcal infection was 
considered optimal therapy by one reviewer be- 
cause of its narrow antistaphylococcal spectrum. 
The other reviewer agreed with the continuation 
of the empirically prescribed cefazolin, which is al- 
so effective, conomical, and has fewer side effects 
such as infusion-related phlebitis. In this evalua- 
tion, reviewer 2also considered more prescriptions 
unjustified than reviewer 1. He judged fewer pre- 
scriptions definitely appropriate; this was true for 
all units. 
Comparison of the quality evaluation for the 
three units by reviewer 1before and after the in- 
tervention is shown in Table 3. According to re- 
viewer 1, the overall proportion of prescriptions 
that were considered definitely appropriate (cat- 
egory I) increased from 40 to 53%. Unjustified 
prescriptions (category V) decreased from 13 to 
9%. There were relatively fewer prescriptions 
classified in categories II to IV (inappropriate). 
The main parameters of quality that improved 
were the choice of a more effective antimicrobi- 
al drug (category IVa), optimal dosage (category 
IIa), and dosage frequency (category IIb). The dif- 
ferences were statistically significant for the total 
prescriptions (p = 0.01). There were also signifi- 
cant differences inquality before and after the in- 
tervention i  unit I (p = 0.003) and unit N (p = 
0.002), but not in unit P (p = 0.91), where no or- 
der form was used. According to reviewer 2, 
there were significant differences inquality before 
and after the intervention i  unit N only (data not 
shown). 
Discussion 
Improper antimicrobial drug use contributes to 
emergence of resistant strains and to waste of 
health resources. Guidelines for improving the use 
of antimicrobial gents in hospitals issued by the 
Infectious Diseases Society of America have rec- 
ommended various tactics (16), including forma- 
tion of antimicrobial gent eams to select drugs 
and organize ducational programs. The recom- 
mendations further include implementation f 
methods that improve selection, such as the use of 
antibiotic order forms, automatic stop orders, 
limited susceptibility reporting, concurrent mon- 
itoring of use and specific audits. Finally, regula- 
tion of the promotional efforts by the pharmaceu- 
tical industry is recommended. 
In our hospital, as in almost every other hospital 
in the Netherlands, a limited hospital formulary of 
antimicrobial drugs composed by antimicrobial 
agent eams and limited susceptibility reports by 
the laboratory have been functional for many 
years. In the first audit described in this study, we 
could not detect any major misuse cited by Marr 
et al. (16), such as excessive duration of therapy 
or concurrent use of more than two drugs. In fact, 
we found a certain degree of underuse. We project- 
ed that implementing a policy to improve quality 
would result in a cost increase. Although quanti- 
tative use after the intervention increased in 
terms of DDD/100 bed days, the proportion of pa- 
tients who were receiving antimicrobial drugs 
was lower than before. This finding can be ex- 
plained by the use of higher dosages and/or long- 
er duration of treatment restricted to patients with 
proven infections and by the shorter length of stay. 
Total cost/bed ay increased for the same reason 
and because of the justified use of more expensive 
drugs with a broader spectrum. 
Apart from correctly estimating the cost of future 
policy changes, the method of quality evaluation 
by two independent reviewers howed that there 
can be different alternatives for an antimicrobial 
therapy regimen. Part of the disagreement be- 
tween reviewers can be explained not only by the 
preference ofdifferent alternatives, but also by re- 
viewer l's involvement in the education program. 
Personal factors (reviewer 2was more strict in his 
evaluation of all units) may also have played a 
role. 
Physicians continue to use antimicrobial drugs in- 
appropriately because knowledge of the basic prin- 
ciples of good antimicrobial therapy is lacking. 
However, education as the single intervention 
strategy to improve quality has not always been suc- 
cessful (7). The order form can help in the proper 
selection of the antimicrobial drug regimen in 
terms of choice, dose, and frequency. Another advan- 
tage of the form is that it requires the prescriber to 
state the suspected causative microorganism. With- 
out an order form, it is not clear whether the pre- 
scriber does not know the potentially causative 
agent or merely fails to mention itin the record, un- 
less the prescriber isinterviewed (t7). 
The order form was successful in stimulating the 
use of standardized dosing frequencies, an effect 
described by others (9). In this way, the order form 
may have contributed toimproved quality of pre- 
scribing. Because we used a combination ofinter- 
vention strategies (education, update of the formu- 
lary, antibiotic order forms), it is not possible to es- 
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timate the effect of each intervention separately. 
The goal of the order form was to facilitate sur- 
veillance. This was aided by having the prescriber 
provide the data for drug utilization, as the in- 
depth reviews had been very time-consuming. No 
immediate action was undertaken to improve 
prescribing at the time of the collection of the 
forms (15). The order form was generally well ac- 
cepted by prescribers. Voluntary compliance was 
high in unit I, with a coverage of more than 80% 
of antimicrobial drug costs. Better compliance 
with the form can be achieved by making the form 
mandatory and controlled by the pharmacy (18). 
In such a setting, the order form offers more op- 
portunities. It can be used to assign automatic dis- 
continuation dates (19), or to initiate an infectious 
diseases consultation for restricted drugs (20). 
Computer system links between orders of antimi- 
crobial drugs and data of the microbiology labo- 
ratory can identify patients whose antibiotic ther- 
apy is inappropriate in relation to sensitivity data 
(21). With the support of the hospital pharmacy, 
the form could be a useful tool for antimicrobial 
drug surveillance and for intervention in Euro- 
pean hospitals in the future. 
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